Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Shares Outstanding (2020 - 2023)

Historic Shares Outstanding for Terns Pharmaceuticals (TERN) over the last 4 years, with Q3 2023 value amounting to $61.8 million.

  • Terns Pharmaceuticals' Shares Outstanding rose 6426.2% to $61.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was $61.8 million, marking a year-over-year increase of 6426.2%. This contributed to the annual value of $53.7 million for FY2022, which is 11260.28% up from last year.
  • According to the latest figures from Q3 2023, Terns Pharmaceuticals' Shares Outstanding is $61.8 million, which was up 6426.2% from $61.1 million recorded in Q2 2023.
  • Over the past 5 years, Terns Pharmaceuticals' Shares Outstanding peaked at $61.8 million during Q3 2023, and registered a low of $215890.0 during Q1 2020.
  • Over the past 4 years, Terns Pharmaceuticals' median Shares Outstanding value was $25.3 million (recorded in 2021), while the average stood at $28.2 million.
  • Its Shares Outstanding has fluctuated over the past 5 years, first surged by 1149930.43% in 2021, then soared by 90.86% in 2022.
  • Over the past 4 years, Terns Pharmaceuticals' Shares Outstanding (Quarter) stood at $337508.0 in 2020, then skyrocketed by 7387.01% to $25.3 million in 2021, then soared by 112.6% to $53.7 million in 2022, then rose by 15.01% to $61.8 million in 2023.
  • Its last three reported values are $61.8 million in Q3 2023, $61.1 million for Q2 2023, and $56.7 million during Q1 2023.